Vitae Pharmaceuticals
A clinical-stage biopharmaceutical company building a portfolio of novel, small molecule, best-in-class compounds.
Launch date
Employees
Market cap
-
Enterprise valuation
€581m (Public information from Sep 2016)
Upper Merion Township Pennsylvania (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
$15.0m | Series B | ||
$34.0m | Series B | ||
$15.0m | Series C | ||
$15.0m | Series D | ||
N/A | $15.0m | Late VC | |
N/A | $65.0m Valuation: $198m | IPO | |
$639m Valuation: $639m | Acquisition | ||
Total Funding | €85.5m |
Recent News about Vitae Pharmaceuticals
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.